×
Hero Background
English
Chinese
French
Japanese
Korean
German
Spanish

China Fertility Services Market Trends

ID: MRFR/HC/5690-HCR
200 Pages
Rahul Gotadki
October 2025

China Fertility Services Market Research Report By Underlying Cause (Male Infertility, Female Infertility) and By Treatment Type (ART, Infertility Drugs)-Forecast to 2035

Share:
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

China Fertility Services Market Infographic
Purchase Options

Market Trends

Key Emerging Trends in the China Fertility Services Market

The China pregnancy Services market is becoming more aware of and open to these changes as people's ideas about pregnancy problems begin to shift. Being open about sexual health is making more people and couples want to use fertility services to help them plan their children. In China, more and more people are putting off having children, which is making more people need fertility services. Because they want to go to college, get ahead at work, or move, a lot of people are putting off having kids. To put it another way, they need help getting pregnant. China has taken steps to help women who are having trouble giving birth because it knows that having too many people can be a problem. The market is being shaped by rules and prizes to get more people to have children. Changes are also being made to the law to help fertility service companies grow. Inside-cell sperm injection (ICSI), preimplantation genetic testing (PGT), and in vitro fertilization (IVF) are some of the assisted reproductive technologies that are quickly growing in the China Fertility Services market. These tools have made more methods work, which gives women more ways to get pregnant. More and more people are having trouble getting pregnant because of things in their surroundings or changes in their lifestyle, like stressing more and working out less. People want fertility services that take into account both medical and social problems that have a bigger effect on sexual health in order for this to happen. There are more and more services that freeze and store eggs because people are putting off having kids. Women who pay for these services want to be able to have children at a younger age. As they age, it gets harder for them to have babies. It's good for the market that China is getting more baby centers and other specialized places. There are more and more companies from inside and outside the country getting into the fertility business as the need for all-around options grows. The market is changed by the fact that more people know about issues with men getting pregnant. Men go to fertility services to get checked out and given care. This is a part of a bigger plan to help both men and women who are having trouble getting pregnant. More and more fertility companies are using online and digital health choices. More and more people are using apps that keep track of pregnancy, hold meetings online, and keep an eye on things from afar. More people can get fertility care because these choices make it easy for them to do so. The way pregnant women in China get help has changed over the years. Fertility services are becoming more popular as a way to plan a family because fewer people feel bad about not being able to have children. People are going on vacation to China and getting pregnant while they are there. Fertility centers in China and other countries have agreements and ties that make it easy for experts to share what they know and the best ways to do things. There are now more options for people who want to get pregnant. Things are getting better, but cost and access are still problems. Many people and couples have trouble getting the help they need to get pregnant. To help a lot more people use birth control, these problems need to be fixed.

Author
Rahul Gotadki
Assistant Manager

He holds an experience of about 7+ years in Market Research and Business Consulting, working under the spectrum of Life Sciences and Healthcare domains. Rahul conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. His expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc. In addition to the above, his other responsibility includes strategic tracking of high growth markets & advising clients on the potential areas of focus they could direct their business initiatives

Leave a Comment

FAQs

What is the expected market size of the China Fertility Services Market in 2024?

<p>The China Fertility Services Market is expected to be valued at 2.58 USD Billion in 2024.</p>

What is the projected market size of the China Fertility Services Market by 2035?

<p>By 2035, the market is projected to reach a valuation of 9.15 USD Billion.</p>

What is the expected compound annual growth rate (CAGR) for the China Fertility Services Market between 2025 and 2035?

<p>The expected CAGR for the China Fertility Services Market between 2025 and 2035 is 12.197 percent.</p>

Which underlying cause segments dominate the China Fertility Services Market?

<p>The underlying cause segments include Male Infertility and Female Infertility, with respective market values increasing significantly by 2035.</p>

How much is the market for Male Infertility valued at in 2024, and what is its expected growth by 2035?

<p>The Male Infertility segment is valued at 1.04 USD Billion in 2024 and is expected to grow to 3.65 USD Billion by 2035.</p>

What is the expected market size for Female Infertility in 2024 and 2035?

<p>The Female Infertility market is expected to be valued at 1.54 USD Billion in 2024, rising to 5.5 USD Billion by 2035.</p>

Who are the key players in the China Fertility Services Market?

<p>Major players include the Reproductive Health Institute of Shanghai, Peking University Third Hospital, and BGI Genomics, among others.</p>

What market growth trends can be anticipated for the China Fertility Services Market?

<p>Emerging trends include increased investments in reproductive technologies and a growing awareness of fertility issues.</p>

What challenges does the China Fertility Services Market face?

<p>Key challenges include regulatory hurdles and the high costs associated with fertility treatments.</p>

How does regionality affect the China Fertility Services Market?

<p>Different regions in China may exhibit varying demand and access to fertility services, influencing market performance overall.</p>

Market Summary

As per MRFR analysis, the fertility services market size was estimated at 3750.0 USD Million in 2024. The fertility services market is projected to grow from 4168.12 USD Million in 2025 to 12000.0 USD Million by 2035, exhibiting a compound annual growth rate (CAGR) of 11.15% during the forecast period 2025 - 2035.

Key Market Trends & Highlights

The China fertility services market is experiencing robust growth driven by increasing demand and supportive government policies.

  • The market is witnessing a rising demand for assisted reproductive technologies, particularly in urban areas. Government support and policy initiatives are enhancing accessibility to fertility treatments across the nation. Technological advancements in fertility treatments are contributing to improved success rates and patient satisfaction. Key market drivers include increasing infertility rates and evolving societal norms that promote family planning and reproductive health.

Market Size & Forecast

2024 Market Size 3750.0 (USD Million)
2035 Market Size 12000.0 (USD Million)
CAGR (2025 - 2035) 11.15%

Major Players

<p>IVF Australia (AU), Fertility Centers of Illinois (US), CCRM Fertility (US), New Hope Fertility Center (US), Reproductive Health Specialists (US), Clinica de Fertilidad (ES), Fertility Associates (NZ), Bourn Hall Clinic (GB), <a href="https://www.ivf-spain.com/en/">IVF Spain</a> (ES)</p>

Market Trends

The fertility services market in China is currently experiencing notable growth, driven by various factors including changing societal norms and increasing awareness of reproductive health. As more individuals and couples seek assistance in conceiving, the demand for advanced reproductive technologies and services has surged. This trend is further supported by government initiatives aimed at addressing declining birth rates and promoting family planning. The landscape is evolving, with a growing number of clinics and healthcare providers offering a range of fertility treatments, from in vitro fertilization (IVF) to egg freezing. Moreover, the fertility services market is witnessing a shift towards personalized care, where treatments are tailored to meet the unique needs of patients. This approach not only enhances the chances of successful outcomes but also improves the overall patient experience. As the stigma surrounding infertility diminishes, more people are likely to seek help, contributing to the market's expansion. The integration of technology, such as telemedicine and artificial intelligence, is also playing a crucial role in transforming service delivery, making it more accessible and efficient. Overall, the fertility services market is poised for continued growth as it adapts to the evolving needs of the population.

Rising Demand for Assisted Reproductive Technologies

The fertility services market is witnessing an increase in demand for assisted reproductive technologies, such as IVF and ICSI. This trend is largely influenced by changing societal attitudes towards family planning and reproductive health. As more individuals and couples face challenges in conceiving, they are turning to these advanced medical solutions to achieve their family goals.

Government Support and Policy Initiatives

Government policies aimed at addressing declining birth rates are significantly impacting the fertility services market. Initiatives that promote family planning and provide financial assistance for fertility treatments are encouraging more couples to seek help. This support is likely to enhance accessibility and affordability, thereby stimulating market growth.

Technological Advancements in Fertility Treatments

The integration of technology in the fertility services market is transforming treatment options. Innovations such as telemedicine, AI-driven diagnostics, and improved laboratory techniques are enhancing the efficiency and effectiveness of fertility treatments. These advancements not only improve success rates but also make services more accessible to a broader population.

China Fertility Services Market Market Drivers

Evolving Societal Norms

In China, changing societal norms regarding family and childbearing are influencing the fertility services market. As more individuals prioritize career development and personal goals, the average age of first-time parents has risen. This shift has led to a growing recognition of the challenges associated with later pregnancies, prompting couples to explore fertility services. The fertility services market is adapting to these evolving norms by offering tailored solutions that cater to the needs of older parents. Additionally, the increasing acceptance of assisted reproductive technologies is likely to drive market growth, as couples become more open to seeking help in their reproductive journeys. This cultural transformation may result in a more proactive approach to fertility, further stimulating demand for services.

Rising Health Awareness

The fertility services market in China is experiencing a surge in demand due to increasing health awareness among the population. As individuals become more informed about reproductive health and the factors affecting fertility, there is a growing inclination to seek professional help. Educational initiatives and media coverage surrounding fertility issues are contributing to this trend, fostering a culture of openness regarding reproductive challenges. The fertility services market is responding by expanding its offerings and improving accessibility to services. This heightened awareness not only encourages couples to pursue fertility treatments but also promotes preventive measures that can enhance reproductive health. As health consciousness continues to rise, the market is likely to see sustained growth in the coming years.

Increasing Infertility Rates

The fertility services market in China is experiencing growth due to rising infertility rates, which have been reported to affect approximately 15% of couples. Factors contributing to this trend include delayed childbearing, lifestyle changes, and environmental influences. As more couples seek assistance, the demand for fertility services is likely to increase. This trend is further supported by the growing awareness of reproductive health issues, leading to a greater willingness to seek medical intervention. The fertility services market is thus positioned to expand, as healthcare providers enhance their offerings to meet the needs of this demographic. With the increasing prevalence of infertility, the market is expected to see a surge in demand for various treatments, including in vitro fertilization (IVF) and other assisted reproductive technologies.

Advancements in Medical Technology

The fertility services market in China is benefiting from rapid advancements in medical technology. Innovations in reproductive medicine, such as improved IVF techniques and genetic screening, are enhancing success rates for fertility treatments. The introduction of new technologies, including artificial intelligence and telemedicine, is also streamlining the patient experience and making services more accessible. As these advancements continue to evolve, the fertility services market is likely to see increased investment and research, leading to more effective treatment options. The integration of cutting-edge technology not only improves outcomes but also attracts a broader patient base, thereby expanding the market. This trend suggests a promising future for the industry as it embraces technological progress.

Government Initiatives and Funding

Government initiatives aimed at addressing population decline in China are playing a crucial role in the fertility services market. Policies that promote family planning and provide financial support for fertility treatments are likely to encourage couples to seek assistance. For instance, subsidies for IVF procedures and tax incentives for families can alleviate the financial burden associated with fertility services. The fertility services market is thus positioned to benefit from these supportive measures, as they may lead to increased utilization of services. Furthermore, public awareness campaigns about reproductive health can enhance understanding and acceptance of fertility treatments, potentially driving market growth. The proactive stance of the government indicates a commitment to improving reproductive health outcomes.

Market Segment Insights

By Treatment Type: In Vitro Fertilization (Largest) vs. Intracytoplasmic Sperm Injection (Fastest-Growing)

<p>In the China fertility services market, In Vitro Fertilization (IVF) holds the largest market share among treatment types, being widely recognized as the most effective method for assisted reproduction. Significant adoption of IVF has solidified its position, making it a first-line treatment for couples facing infertility challenges. Conversely, Intracytoplasmic Sperm Injection (ICSI) is rapidly gaining traction due to its success in treating male infertility issues, thereby expanding the treatment options available for patients. Growth trends in this segment are heavily influenced by increasing awareness and acceptance of reproductive technologies among couples. Additionally, advancements in medical technologies and techniques are driving innovation in treatments like ICSI, making it more efficient and accessible. The rising number of fertility clinics and enhanced governmental support also contribute to the expansion of these treatments, particularly IVF and ICSI, as they become increasingly recognized as viable solutions for infertility.</p>

<p>In Vitro Fertilization (Dominant) vs. Intracytoplasmic Sperm Injection (Emerging)</p>

<p>In Vitro Fertilization (IVF) remains the dominant treatment type in the market, known for its high success rates and comprehensive approach to infertility management. IVF involves retrieving eggs from a woman's ovaries and fertilizing them with sperm in a laboratory setting, allowing for better control over the fertilization process and genetic screening opportunities. In contrast, Intracytoplasmic Sperm Injection (ICSI) is an emerging treatment that focuses specifically on male infertility. ICSI involves injecting a single sperm directly into an egg, making it particularly advantageous for couples with male-factor infertility issues. Both treatment types complement each other, with IVF catering to a broader audience while ICSI offers targeted solutions, thereby broadening the market's scope.</p>

By Patient Type: Female Infertility (Largest) vs. Same-Sex Couples (Fastest-Growing)

<p>In the China fertility services market, the segmentation by patient type reveals that female infertility holds the largest share, driven by a growing awareness about reproductive health and the increasing prevalence of infertility among women. Male infertility is also significant, but it lags behind female infertility, while couples with unexplained infertility and single parents represent smaller portions of the market. The rising acceptance of same-sex couples seeking fertility services demonstrates a shift towards inclusivity in reproductive healthcare. Growth trends in this segment are being influenced by several factors, including advancements in reproductive technologies and a more supportive legislative environment for same-sex couples. The market is likely to experience increased demand for tailored services that cater to diverse patient types, particularly as societal attitudes continue to evolve. This adaptation combined with ongoing healthcare education and outreach efforts will be pivotal in driving future growth in the segment.</p>

<p>Female Infertility: Dominant vs. Same-Sex Couples: Emerging</p>

<p>Female infertility is characterized by a range of factors affecting women's reproductive health, including age, lifestyle, and medical conditions. This patient type dominates the China fertility services market due to increasing awareness and proactive approaches to address infertility. In contrast, same-sex couples represent an emerging segment as they gain access to fertility services and support networks. This trend reflects a broader cultural acceptance of diverse family structures. Providers are adapting to meet the unique needs of same-sex couples, fostering an inclusive environment that recognizes their reproductive aspirations. The contrasting dynamics between these patient types highlight the multifaceted nature of the market, where traditional and emerging demands coexist.</p>

By End User: Fertility Clinics (Largest) vs. Hospitals (Fastest-Growing)

<p>In the China fertility services market, Fertility Clinics are the dominant players, holding a significant share due to their specialized services and personalized treatments. Hospitals also contribute to the landscape but to a lesser extent, providing fertility services as part of a broader range of medical solutions. The market distribution indicates a strong preference for clinics that focus solely on fertility treatments, showcasing their appeal among patients seeking dedicated care. Growth trends in this segment are influenced by increasing awareness of fertility issues and advancements in reproductive technologies. Fertility Clinics continue to grow due to their ability to offer tailored solutions and cutting-edge procedures. Conversely, Hospitals are emerging as a faster-growing segment as they integrate fertility services into comprehensive healthcare offerings, appealing to patients looking for a one-stop solution.</p>

<p>Fertility Clinics (Dominant) vs. Hospitals (Emerging)</p>

<p>Fertility Clinics are characterized by their specialization in reproductive health, offering a range of services from IVF to egg donation. This focus allows them to stay ahead in delivering personalized care and advanced techniques, resulting in a loyal patient base. The infrastructure of these clinics is typically more conducive to fertility treatments, attracting those who prioritize targeted interventions. In contrast, Hospitals are increasingly seen as an emerging option in the China fertility services market, expanding their offerings to include fertility treatments as ancillary services. Their growth is fueled by the convenience of integrated care, drawing patients who prefer receiving multiple health services in one location. This dynamic is reshaping the competitive landscape, leading to an evolving patient preference pattern.</p>

By Service Type: Consultation Services (Largest) vs. Treatment Services (Fastest-Growing)

<p>In the China fertility services market, market share among service types reveals that consultation services hold a significant portion, dominating the landscape. Diagnostic services also play a crucial role, while treatment services, though smaller in share, are characterized by rapid growth, appealing to healthcare providers and patients alike. Each segment serves essential functions in supporting fertility management through targeted offerings. Growth trends in this market indicate a surge in demand for treatment services, driven by rising infertility rates and increased awareness of reproductive health. The ease of access to advanced technologies and procedures further fuels this growth, establishing treatment services as a focal point of innovation. Consultation services, while established, continue to evolve by incorporating new approaches to patient care and education, ensuring their relevance in a competitive market.</p>

<p>Consultation Services (Dominant) vs. Treatment Services (Emerging)</p>

<p>Consultation services stand as the dominant segment in the China fertility services market, providing essential foundational support for patients navigating fertility options. These services focus on patient education, individualized care plans, and psychological support, ensuring that individuals and couples receive comprehensive guidance throughout their fertility journey. Contrastingly, treatment services represent an emerging and dynamic area, with significant advancements in methodologies such as IVF and assisted reproductive technologies. Their rapid growth indicates an increasing demand for innovative solutions to infertility challenges, attracting investments and new players to the market. Together, these segments create a robust ecosystem, balancing established practices with progressive treatment methodologies.</p>

Get more detailed insights about China Fertility Services Market Research Report-Forecast to 2035

Regional Insights

Key Players and Competitive Insights

The fertility services market in China is characterized by a dynamic competitive landscape, driven by increasing demand for assisted reproductive technologies (ART) and a growing awareness of fertility issues among the population. Key players are actively positioning themselves through innovation, strategic partnerships, and regional expansions. Notably, companies such as IVF Australia (AU), CCRM Fertility (US), and Fertility Associates (NZ) are leveraging their expertise to enhance service offerings and improve patient outcomes. Their collective strategies not only foster competition but also contribute to the overall growth of the market, as they adapt to the evolving needs of consumers seeking fertility solutions.

In terms of business tactics, companies are increasingly localizing their operations to better serve the Chinese market, optimizing supply chains to ensure efficiency and reliability. The competitive structure of the market appears moderately fragmented, with several players vying for market share. This fragmentation allows for diverse service offerings, yet the influence of major players remains significant, as they set benchmarks for quality and innovation that smaller entities strive to meet.

In October 2025, CCRM Fertility (US) announced a partnership with a leading Chinese healthcare provider to expand its reach in the region. This strategic move is likely to enhance CCRM's operational capabilities and provide access to a broader patient base, thereby solidifying its position in the market. The collaboration may also facilitate knowledge transfer and best practices in ART, which could elevate service standards across the board.

In September 2025, IVF Australia (AU) launched a new telehealth platform aimed at improving patient access to fertility consultations. This initiative reflects a growing trend towards digital transformation in healthcare, particularly in fertility services, where convenience and accessibility are paramount. By integrating technology into its service model, IVF Australia is likely to enhance patient engagement and streamline the consultation process, potentially leading to higher conversion rates for treatment.

In November 2025, Fertility Associates (NZ) unveiled a new research initiative focused on genetic screening technologies. This development underscores the increasing importance of personalized medicine in fertility treatments. By investing in cutting-edge research, Fertility Associates aims to differentiate itself in a competitive market, potentially leading to improved success rates and patient satisfaction.

As of November 2025, current trends in the fertility services market are heavily influenced by digitalization, sustainability, and the integration of artificial intelligence (AI) into treatment protocols. Strategic alliances are becoming more prevalent, as companies recognize the value of collaboration in enhancing service delivery and innovation. Looking ahead, competitive differentiation is expected to shift from price-based strategies to a focus on technological advancements, innovative treatment options, and robust supply chain management, ultimately shaping a more resilient and responsive market.

Key Companies in the China Fertility Services Market market include

Industry Developments

In recent months, the China Fertility Services Market has seen significant developments, particularly among leading institutions like the Reproductive Health Institute of Shanghai and Peking University Third Hospital, which continue to expand their fertility treatment capabilities in response to increasing demand. The market is also influenced by ongoing governmental initiatives aimed at increasing birth rates and improving reproductive health, with notable discussions around policies and funding to support fertility treatments.

In terms of mergers and acquisitions, Bohua Zhihe has garnered attention following its acquisition of a smaller clinic in September 2023, enhancing its service offerings.Additionally, BGI Genomics, known for its advancements in genomic technologies, has expanded its collaboration with universities such as Nanjing Medical University to innovate in reproductive health research. The overall market valuation for fertility services in China continues to grow, indicating a robust demand for IVF and other services.

Major developments over the past few years, especially post-2020, have led to a heightened focus on reproductive health and fertility treatment mechanisms, driven by changing societal norms and government support, indicating a pivotal shift in how fertility services are perceived and utilized in China.

Future Outlook

China Fertility Services Market Future Outlook

<p>The fertility services market in China is projected to grow at 11.15% CAGR from 2024 to 2035, driven by increasing infertility rates, technological advancements, and rising awareness.</p>

New opportunities lie in:

  • <p>Expansion of telehealth services for remote consultations and follow-ups.</p>
  • <p>Development of personalized fertility treatment plans using AI analytics.</p>
  • <p>Investment in cryopreservation technologies for long-term storage solutions.</p>

<p>By 2035, the market is expected to achieve substantial growth, driven by innovation and increased accessibility.</p>

Market Segmentation

China Fertility Services Market End User Outlook

  • Fertility Clinics
  • Hospitals
  • Home Care

China Fertility Services Market Patient Type Outlook

  • Female Infertility
  • Male Infertility
  • Couples with Unexplained Infertility
  • Same-Sex Couples
  • Single Parents

China Fertility Services Market Service Type Outlook

  • Consultation Services
  • Diagnostic Services
  • Treatment Services

China Fertility Services Market Treatment Type Outlook

  • In Vitro Fertilization
  • Intracytoplasmic Sperm Injection
  • Artificial Insemination
  • Donor Egg
  • Surrogacy

Report Scope

MARKET SIZE 2024 3750.0(USD Million)
MARKET SIZE 2025 4168.12(USD Million)
MARKET SIZE 2035 12000.0(USD Million)
COMPOUND ANNUAL GROWTH RATE (CAGR) 11.15% (2024 - 2035)
REPORT COVERAGE Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
BASE YEAR 2024
Market Forecast Period 2025 - 2035
Historical Data 2019 - 2024
Market Forecast Units USD Million
Key Companies Profiled IVF Australia (AU), Fertility Centers of Illinois (US), CCRM Fertility (US), New Hope Fertility Center (US), Reproductive Health Specialists (US), Clinica de Fertilidad (ES), Fertility Associates (NZ), Bourn Hall Clinic (GB), IVF Spain (ES)
Segments Covered Treatment Type, Patient Type, End User, Service Type
Key Market Opportunities Integration of advanced reproductive technologies and personalized treatment plans in the fertility services market.
Key Market Dynamics Rising demand for advanced reproductive technologies drives innovation and competition in the fertility services market.
Countries Covered China

FAQs

What is the expected market size of the China Fertility Services Market in 2024?

<p>The China Fertility Services Market is expected to be valued at 2.58 USD Billion in 2024.</p>

What is the projected market size of the China Fertility Services Market by 2035?

<p>By 2035, the market is projected to reach a valuation of 9.15 USD Billion.</p>

What is the expected compound annual growth rate (CAGR) for the China Fertility Services Market between 2025 and 2035?

<p>The expected CAGR for the China Fertility Services Market between 2025 and 2035 is 12.197 percent.</p>

Which underlying cause segments dominate the China Fertility Services Market?

<p>The underlying cause segments include Male Infertility and Female Infertility, with respective market values increasing significantly by 2035.</p>

How much is the market for Male Infertility valued at in 2024, and what is its expected growth by 2035?

<p>The Male Infertility segment is valued at 1.04 USD Billion in 2024 and is expected to grow to 3.65 USD Billion by 2035.</p>

What is the expected market size for Female Infertility in 2024 and 2035?

<p>The Female Infertility market is expected to be valued at 1.54 USD Billion in 2024, rising to 5.5 USD Billion by 2035.</p>

Who are the key players in the China Fertility Services Market?

<p>Major players include the Reproductive Health Institute of Shanghai, Peking University Third Hospital, and BGI Genomics, among others.</p>

What market growth trends can be anticipated for the China Fertility Services Market?

<p>Emerging trends include increased investments in reproductive technologies and a growing awareness of fertility issues.</p>

What challenges does the China Fertility Services Market face?

<p>Key challenges include regulatory hurdles and the high costs associated with fertility treatments.</p>

How does regionality affect the China Fertility Services Market?

<p>Different regions in China may exhibit varying demand and access to fertility services, influencing market performance overall.</p>

  1. SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
    1. EXECUTIVE SUMMARY
      1. Market Overview
      2. Key Findings
      3. Market Segmentation
      4. Competitive Landscape
      5. Challenges and Opportunities
      6. Future Outlook 2
  2. SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
    1. MARKET INTRODUCTION
      1. Definition
      2. Scope of the study
    2. RESEARCH METHODOLOGY
      1. Overview
      2. Data Mining
      3. Secondary Research
      4. Primary Research
      5. Forecasting Model
      6. Market Size Estimation
      7. Data Triangulation
      8. Validation 3
  3. SECTION III: QUALITATIVE ANALYSIS
    1. MARKET DYNAMICS
      1. Overview
      2. Drivers
      3. Restraints
      4. Opportunities
    2. MARKET FACTOR ANALYSIS
      1. Value chain Analysis
      2. Porter's Five Forces Analysis
      3. COVID-19 Impact Analysis
  4. SECTION IV: QUANTITATIVE ANALYSIS
    1. Healthcare, BY Treatment Type (USD Million)
      1. In Vitro Fertilization
      2. Intracytoplasmic Sperm Injection
      3. Artificial Insemination
      4. Donor Egg
      5. Surrogacy
    2. Healthcare, BY Patient Type (USD Million)
      1. Female Infertility
      2. Male Infertility
      3. Couples with Unexplained Infertility
      4. Same-Sex Couples
      5. Single Parents
    3. Healthcare, BY End User (USD Million)
      1. Fertility Clinics
      2. Hospitals
      3. Home Care
    4. Healthcare, BY Service Type (USD Million)
      1. Consultation Services
      2. Diagnostic Services
      3. Treatment Services 5
  5. SECTION V: COMPETITIVE ANALYSIS
    1. Competitive Landscape
      1. Overview
      2. Competitive Analysis
      3. Market share Analysis
      4. Major Growth Strategy in the Healthcare
      5. Competitive Benchmarking
      6. Leading Players in Terms of Number of Developments in the Healthcare
      7. Key developments and growth strategies
      8. Major Players Financial Matrix
    2. Company Profiles
      1. IVF Australia (AU)
      2. Fertility Centers of Illinois (US)
      3. CCRM Fertility (US)
      4. New Hope Fertility Center (US)
      5. Reproductive Health Specialists (US)
      6. Clinica de Fertilidad (ES)
      7. Fertility Associates (NZ)
      8. Bourn Hall Clinic (GB)
      9. IVF Spain (ES)
    3. Appendix
      1. References
      2. Related Reports 6 LIST OF FIGURES
    4. MARKET SYNOPSIS
    5. CHINA MARKET ANALYSIS BY TREATMENT TYPE
    6. CHINA MARKET ANALYSIS BY PATIENT TYPE
    7. CHINA MARKET ANALYSIS BY END USER
    8. CHINA MARKET ANALYSIS BY SERVICE TYPE
    9. KEY BUYING CRITERIA OF HEALTHCARE
    10. RESEARCH PROCESS OF MRFR
    11. DRO ANALYSIS OF HEALTHCARE
    12. DRIVERS IMPACT ANALYSIS: HEALTHCARE
    13. RESTRAINTS IMPACT ANALYSIS: HEALTHCARE
    14. SUPPLY / VALUE CHAIN: HEALTHCARE
    15. HEALTHCARE, BY TREATMENT TYPE, 2024 (% SHARE)
    16. HEALTHCARE, BY TREATMENT TYPE, 2024 TO 2035 (USD Million)
    17. HEALTHCARE, BY PATIENT TYPE, 2024 (% SHARE)
    18. HEALTHCARE, BY PATIENT TYPE, 2024 TO 2035 (USD Million)
    19. HEALTHCARE, BY END USER, 2024 (% SHARE)
    20. HEALTHCARE, BY END USER, 2024 TO 2035 (USD Million)
    21. HEALTHCARE, BY SERVICE TYPE, 2024 (% SHARE)
    22. HEALTHCARE, BY SERVICE TYPE, 2024 TO 2035 (USD Million)
    23. BENCHMARKING OF MAJOR COMPETITORS 7 LIST OF TABLES
    24. LIST OF ASSUMPTIONS
    25. China MARKET SIZE ESTIMATES; FORECAST
      1. BY TREATMENT TYPE, 2025-2035 (USD Million)
      2. BY PATIENT TYPE, 2025-2035 (USD Million)
      3. BY END USER, 2025-2035 (USD Million)
      4. BY SERVICE TYPE, 2025-2035 (USD Million)
    26. PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
    27. ACQUISITION/PARTNERSHIP

China Healthcare Market Segmentation

Healthcare By Treatment Type (USD Million, 2025-2035)

  • In Vitro Fertilization
  • Intracytoplasmic Sperm Injection
  • Artificial Insemination
  • Donor Egg
  • Surrogacy

Healthcare By Patient Type (USD Million, 2025-2035)

  • Female Infertility
  • Male Infertility
  • Couples with Unexplained Infertility
  • Same-Sex Couples
  • Single Parents

Healthcare By End User (USD Million, 2025-2035)

  • Fertility Clinics
  • Hospitals
  • Home Care

Healthcare By Service Type (USD Million, 2025-2035)

  • Consultation Services
  • Diagnostic Services
  • Treatment Services
Infographic

Free Sample Request

Kindly complete the form below to receive a free sample of this Report

Get Free Sample

Customer Strories

“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

Victoria Milne

Founder

Compare Licence

×
Features License Type
Single User Multiuser License Enterprise User
Price $4,950 $5,950 $7,250
Maximum User Access Limit 1 User Upto 10 Users Unrestricted Access Throughout the Organization
Free Customization
Direct Access to Analyst
Deliverable Format
Platform Access
Discount on Next Purchase 10% 15% 15%
Printable Versions